CereVasc and LianMedical Partner to Bring Innovative eShunt® System to Asian Markets

Image Source : Public Domain

CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, and LianMedical, a medical device company focused on accelerating the introduction of breakthrough medical technologies to markets in Asia, announced  a partnership focused on bringing CereVasc's eShunt^® System and related products to patients and providers in China, Hong Kong, Taiwan, and Macaw.

"We are very excited by the opportunity for our products to improve the standard of care for patients with hydrocephalus in these territories and believe we have identified the ideal partner in LianMedical to support these expansion efforts," said Dan Levangie, President & CEO of CereVasc, Inc.  Luxin Wang, CEO of LianMedical, continued "There is significant unmet clinical need in Hydrocephalus treatment in Asia. The eShunt^® System is an innovation that can potentially revolutionize the standard of care and benefit thousands of patients. We are excited to partner with Dan and his team to capitalize on this significant opportunity."